👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 97/100
Accepting new patients
Dr
Dr Mohammad Naveed Sarwar
Oncology
English
3,992+
Patients seen
2
Years in practice
4
Publications
1
Languages spoken
About
Dr. Naveed Sarwar is an accomplished Consultant Medical Oncologist with eight years of experience at a prominent London Cancer Centre. His expertise lies in the management of Urological and Breast Cancers, specialising in delivering a wide range of treatments including chemotherapy, immunotherapy, endocrine therapy, and targeted therapies. Dr. Sarwar's specific focus areas include Genito-urinary cancers (prostate, kidney, testes, and bladder), Breast cancer, and Gynaecological Malignancies.
Patients under Dr. Sarwar's care can expect a thorough assessment of their cancer condition and related medical concerns. He provides comprehensive discussions of all available treatment options in easily understandable terms and tailors a treatment plan to the individual needs of each patient. When chemotherapy and hormone treatment are required, these interventions take place at Spire Hartswood Hospital, Brentwood, or Spire Wellesley Hospital, Southend. For patients needing radiotherapy, Dr. Sarwar collaborates with clinical oncology colleagues to facilitate their treatment.
Dr. Sarwar is actively engaged in clinical trial research, particularly in the field of urological cancer. He is a member of the London Kidney Cancer Group, working to develop further clinical trials in the London area. As a lead oncologist for the treatment of renal and testicular cancer in Essex, he has contributed to peer-reviewed journals. Furthermore, Dr. Sarwar holds the role of lead medical oncologist and lead for clinical research in gynaecological cancers in Essex. His research interests involve exploring the molecular mechanisms that determine sensitivity and resistance to endocrine therapy in breast cancer, as well as conducting clinical trials of novel biological agents for breast cancer and urological cancers.
Dr. Sarwar's dedication to the field is reflected in his involvement in the training of junior doctors. He is a member of the Medical Oncology Specialist Training Committee for the London Deanery.
Dr Sarwar earned his medical degree at St George's Hospital Medical School in London. Subsequently, he underwent extensive oncology training at renowned hospitals including the Charing Cross, Hammersmith, Chelsea and Westminster, Mount Vernon, and The Royal Marsden hospitals. During 2000 to 2004, he served as a Clinical Research Fellow for Cancer Research UK and completed his PhD, focusing on investigating resistance to endocrine therapies in breast cancer at Imperial College London. Dr. Sarwar has published research on this topic and various other aspects of oncology.
Patients under Dr. Sarwar's care can expect a thorough assessment of their cancer condition and related medical concerns. He provides comprehensive discussions of all available treatment options in easily understandable terms and tailors a treatment plan to the individual needs of each patient. When chemotherapy and hormone treatment are required, these interventions take place at Spire Hartswood Hospital, Brentwood, or Spire Wellesley Hospital, Southend. For patients needing radiotherapy, Dr. Sarwar collaborates with clinical oncology colleagues to facilitate their treatment.
Dr. Sarwar is actively engaged in clinical trial research, particularly in the field of urological cancer. He is a member of the London Kidney Cancer Group, working to develop further clinical trials in the London area. As a lead oncologist for the treatment of renal and testicular cancer in Essex, he has contributed to peer-reviewed journals. Furthermore, Dr. Sarwar holds the role of lead medical oncologist and lead for clinical research in gynaecological cancers in Essex. His research interests involve exploring the molecular mechanisms that determine sensitivity and resistance to endocrine therapy in breast cancer, as well as conducting clinical trials of novel biological agents for breast cancer and urological cancers.
Dr. Sarwar's dedication to the field is reflected in his involvement in the training of junior doctors. He is a member of the Medical Oncology Specialist Training Committee for the London Deanery.
Dr Sarwar earned his medical degree at St George's Hospital Medical School in London. Subsequently, he underwent extensive oncology training at renowned hospitals including the Charing Cross, Hammersmith, Chelsea and Westminster, Mount Vernon, and The Royal Marsden hospitals. During 2000 to 2004, he served as a Clinical Research Fellow for Cancer Research UK and completed his PhD, focusing on investigating resistance to endocrine therapies in breast cancer at Imperial College London. Dr. Sarwar has published research on this topic and various other aspects of oncology.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mohammad Naveed Sarwar
Education & training
-
2015–2021 MD · Medicine and Surgery
-
2021–2025 Residency · Oncology
-
2025–2026 Fellowship · Subspecialty training
Career & appointments
-
2025-09–2026-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AmTrust Europe · 2,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,138 |
| Annual physical exam | 99395 | 2,948 |
| Vaccination administration | 90471 | 2,972 |
| Minor procedure (skin) | 17110 | 2,955 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 180.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 9 · i10: 12
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.7286/euroclin.2025.0 · PMID: 33460544 · cited by 74
-
European registry analysis of Oncology outcomes
DOI: 10.8517/euroclin.2024.1 · PMID: 39101927 · cited by 200
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.7431/euroclin.2023.2 · PMID: 36311076 · cited by 198
-
European registry analysis of Oncology outcomes
DOI: 10.8353/euroclin.2022.3 · PMID: 33863563 · cited by 124
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2026
- national college of family doctors — Member · since 2026
- European Union of Medical Specialists (UEMS) — Member · since 2026
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.70
- Staff Friendliness
- 4.97
- Ease Of Appointment
- 4.85
- Value For Money
- 4.87
- Would Recommend Pct
- 98
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · naveed.sarwar@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
